CN101287507A - 用于淋巴靶向的方法和装置 - Google Patents
用于淋巴靶向的方法和装置 Download PDFInfo
- Publication number
- CN101287507A CN101287507A CNA2006800382495A CN200680038249A CN101287507A CN 101287507 A CN101287507 A CN 101287507A CN A2006800382495 A CNA2006800382495 A CN A2006800382495A CN 200680038249 A CN200680038249 A CN 200680038249A CN 101287507 A CN101287507 A CN 101287507A
- Authority
- CN
- China
- Prior art keywords
- implantable device
- granule
- poly
- bioactivator
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/622—Microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/624—Nanocapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Heart & Thoracic Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (72)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210525333.7A CN103315944B (zh) | 2005-08-12 | 2006-08-14 | 用于淋巴靶向的方法和装置 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70753405P | 2005-08-12 | 2005-08-12 | |
US60/707,534 | 2005-08-12 | ||
PCT/CA2006/001321 WO2007019678A1 (en) | 2005-08-12 | 2006-08-14 | Methods and devices for lymphatic targeting |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210525333.7A Division CN103315944B (zh) | 2005-08-12 | 2006-08-14 | 用于淋巴靶向的方法和装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101287507A true CN101287507A (zh) | 2008-10-15 |
CN101287507B CN101287507B (zh) | 2012-12-05 |
Family
ID=37757281
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800382495A Active CN101287507B (zh) | 2005-08-12 | 2006-08-14 | 用于淋巴靶向的方法和装置 |
CN201210525333.7A Active CN103315944B (zh) | 2005-08-12 | 2006-08-14 | 用于淋巴靶向的方法和装置 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210525333.7A Active CN103315944B (zh) | 2005-08-12 | 2006-08-14 | 用于淋巴靶向的方法和装置 |
Country Status (7)
Country | Link |
---|---|
US (2) | US20100278725A1 (zh) |
EP (1) | EP1922094B1 (zh) |
CN (2) | CN101287507B (zh) |
CA (1) | CA2618807C (zh) |
ES (1) | ES2556974T3 (zh) |
HK (2) | HK1123230A1 (zh) |
WO (1) | WO2007019678A1 (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102240265A (zh) * | 2010-05-14 | 2011-11-16 | 复旦大学 | 一种用于肿瘤的靶向递药的脂质体载体系统 |
CN102539760A (zh) * | 2012-02-11 | 2012-07-04 | 刘�东 | 具有体外肿瘤靶向作用的经叶酸配体修饰的氧化铁纳米颗粒与其制备方法及体外评价方法 |
CN101940553B (zh) * | 2009-07-10 | 2012-11-14 | 何彦津 | 叶酸-长春新碱靶向缓释纳米微球及制备方法及用途 |
CN103417468A (zh) * | 2012-05-25 | 2013-12-04 | 王世亮 | 一种依托泊苷植入剂 |
CN103788385A (zh) * | 2013-12-31 | 2014-05-14 | 中国科学院深圳先进技术研究院 | 一种使用喷雾干燥法制备水凝胶光子晶体颗粒的方法 |
CN107635455A (zh) * | 2015-04-03 | 2018-01-26 | 格勒诺布尔-阿尔卑斯大学 | 可植入肠反应器 |
CN109562130A (zh) * | 2016-06-13 | 2019-04-02 | 智能外科公司 | 用于生物系统的组合物以及制备和使用其的方法 |
CN109718228A (zh) * | 2017-10-30 | 2019-05-07 | 沈阳药科大学 | 米托蒽醌的抗肿瘤淋巴转移作用及其药物制剂 |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007047539A2 (en) * | 2005-10-14 | 2007-04-26 | Medtronic, Inc. | Localized delivery to the lymphatic system |
WO2010138192A2 (en) | 2009-05-27 | 2010-12-02 | Selecta Biosciences, Inc. | Nanocarriers possessing components with different rates of release |
EA030620B1 (ru) | 2010-05-26 | 2018-09-28 | Селекта Байосайенсиз, Инк. | Композиции для выработки иммунного ответа к наборам поверхностных антигенов, содержащие синтетические наноносители, и их применение |
US10933129B2 (en) | 2011-07-29 | 2021-03-02 | Selecta Biosciences, Inc. | Methods for administering synthetic nanocarriers that generate humoral and cytotoxic T lymphocyte responses |
WO2014155144A1 (en) | 2013-03-28 | 2014-10-02 | Bbs Nanotechnology Llc | Stable nanocomposition comprising docetaxel, process for the preparation thereof, its use and pharmaceutical compositions containing it |
WO2014155142A1 (en) | 2013-03-28 | 2014-10-02 | Bbs Nanotechnology Ltd. | Stable nanocomposition comprising doxorubicin, process for the preparation thereof, its use and pharmaceutical compositions containing it |
CN104549557B (zh) * | 2013-10-17 | 2018-11-02 | 中国石油化工股份有限公司 | 一种微粒载体的浸渍方法 |
US20150343139A1 (en) * | 2014-05-30 | 2015-12-03 | Boston Scientific Scimed, Inc. | Implantable pumps and related methods of use |
US9844558B1 (en) | 2015-04-30 | 2017-12-19 | Amag Pharmaceuticals, Inc. | Methods of reducing risk of preterm birth |
CN107847447A (zh) * | 2015-06-18 | 2018-03-27 | 灵敏生物公司 | 可植入的药物递送组合物及其使用方法 |
WO2017019535A2 (en) | 2015-07-24 | 2017-02-02 | Kimberly-Clark Worldwide, Inc. | Methods for lymphatic delivery of active agents |
US10556922B2 (en) | 2015-09-29 | 2020-02-11 | Amag Pharmaceuticals, Inc. | Crystalline and amorphous forms of 17-alpha-hydroxyprogesterone caproate |
US10456423B2 (en) | 2016-06-13 | 2019-10-29 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
US10751431B2 (en) | 2016-06-23 | 2020-08-25 | National Guard Health Affairs | Positron emission capsule for image-guided proton therapy |
CN106198170B (zh) * | 2016-06-30 | 2017-08-18 | 华中科技大学 | 一种生物组织包埋剂及包埋方法 |
JP2021524841A (ja) | 2018-05-24 | 2021-09-16 | セラニーズ・イーブイエイ・パフォーマンス・ポリマーズ・エルエルシー | 高分子薬剤化合物の持続放出用の埋め込み型デバイス |
CN111989068A (zh) | 2018-05-24 | 2020-11-24 | 塞拉尼斯伊娃高性能聚合物公司 | 用于持续释放大分子药物化合物的可植入器件 |
KR102142968B1 (ko) * | 2018-06-01 | 2020-08-11 | 연세대학교 원주산학협력단 | 폐질환용 약물 전달체 |
CN109200334B (zh) * | 2018-09-26 | 2021-04-09 | 湖北大学 | 一种光动力治疗伤口感染用的复合水凝胶敷料及其制备方法 |
RU2702596C1 (ru) * | 2018-11-09 | 2019-10-08 | Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Образования "Московский государственный медико-стоматологический университет имени А.И. Евдокимова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО МГМСУ имени А.И. Евдокимова Минздрава России) | Способ лечения послеоперационной лимфореи с использованием фотодинамической терапии |
CN112137961A (zh) * | 2020-09-30 | 2020-12-29 | 严鹏科 | 一种雷帕霉素组合物及其制备方法 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4310505A (en) * | 1979-11-08 | 1982-01-12 | California Institute Of Technology | Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances |
US4292972A (en) * | 1980-07-09 | 1981-10-06 | E. R. Squibb & Sons, Inc. | Lyophilized hydrocolloio foam |
US4544545A (en) * | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
US4735210A (en) * | 1985-07-05 | 1988-04-05 | Immunomedics, Inc. | Lymphographic and organ imaging method and kit |
US5101827A (en) * | 1985-07-05 | 1992-04-07 | Immunomedics, Inc. | Lymphographic and organ imaging method and kit |
US5158538A (en) * | 1988-12-28 | 1992-10-27 | Abbott Laboratories | Regulating peritoneal lymphatic drainage and uses therefor |
US5387623A (en) * | 1991-07-30 | 1995-02-07 | H. B. Fuller Company | Biodegradable adhesive packaging |
DE4201461A1 (de) * | 1992-01-21 | 1993-07-22 | Mueller Schulte Detlef Dr | Mittel fuer die selektive tumortherapie auf der basis ferromagnetischer partikel - verfahren zu ihrer herstellung und verwendung |
EP0654973A4 (en) * | 1992-07-21 | 1995-08-09 | Gen Hospital Corp | LYPHATIC TISSUE DRUG ADMINISTRATION SYSTEM. |
GB9216082D0 (en) * | 1992-07-28 | 1992-09-09 | Univ Nottingham | Lymphatic delivery composition |
US5429133A (en) * | 1992-12-18 | 1995-07-04 | Neoprobe Corporation | Radiation responsive laparoscopic instrument |
CZ288792B6 (cs) * | 1993-12-23 | 2001-09-12 | Johnson & Johnson Medical, Inc. | Bioabsorbovatelný chirurgický hemostat a způsob jeho výroby |
US5626862A (en) * | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
US5660854A (en) * | 1994-11-28 | 1997-08-26 | Haynes; Duncan H | Drug releasing surgical implant or dressing material |
US5560931A (en) * | 1995-02-14 | 1996-10-01 | Nawosystems L.L.C. | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
US6117949A (en) * | 1998-10-01 | 2000-09-12 | Macromed, Inc. | Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
US6537585B1 (en) * | 1999-03-26 | 2003-03-25 | Guilford Pharmaceuticals, Inc. | Methods and compositions for treating solid tumors |
US6726920B1 (en) * | 2000-09-22 | 2004-04-27 | Durect Corporation | Implantable drug delivery patch |
US20040241211A9 (en) * | 2000-11-06 | 2004-12-02 | Fischell Robert E. | Devices and methods for reducing scar tissue formation |
US6473434B1 (en) * | 2001-04-20 | 2002-10-29 | International Business Machines Corporation | Scaleable and robust solution for reducing complexity of resource identifier distribution in a large network processor-based system |
AUPR573001A0 (en) * | 2001-06-15 | 2001-07-12 | Glaxo Wellcome Australia Ltd | Lymphatic drug delivery system |
US6488952B1 (en) * | 2001-08-28 | 2002-12-03 | John P. Kennedy | Semisolid therapeutic delivery system and combination semisolid, multiparticulate, therapeutic delivery system |
ATE295155T1 (de) * | 2001-10-05 | 2005-05-15 | Surmodics Inc | Beschichtungen mit immobilisierten partikeln sowie verwendungen derselben |
ITMI20020681A1 (it) * | 2002-03-29 | 2003-09-29 | Acs Dobfar Spa | Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina |
US7166133B2 (en) * | 2002-06-13 | 2007-01-23 | Kensey Nash Corporation | Devices and methods for treating defects in the tissue of a living being |
US7670627B2 (en) * | 2002-12-09 | 2010-03-02 | Salvona Ip Llc | pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients |
WO2005087221A1 (en) * | 2004-03-15 | 2005-09-22 | Christine Allen | Biodegradable biocompatible implant and method of manufacturing same |
US20050266040A1 (en) * | 2004-05-28 | 2005-12-01 | Brent Gerberding | Medical devices composed of porous metallic materials for delivering biologically active materials |
-
2006
- 2006-08-14 US US12/063,614 patent/US20100278725A1/en not_active Abandoned
- 2006-08-14 CN CN2006800382495A patent/CN101287507B/zh active Active
- 2006-08-14 CA CA2618807A patent/CA2618807C/en active Active
- 2006-08-14 CN CN201210525333.7A patent/CN103315944B/zh active Active
- 2006-08-14 WO PCT/CA2006/001321 patent/WO2007019678A1/en active Application Filing
- 2006-08-14 ES ES06775100.8T patent/ES2556974T3/es active Active
- 2006-08-14 EP EP06775100.8A patent/EP1922094B1/en active Active
-
2009
- 2009-04-14 HK HK09103421.4A patent/HK1123230A1/xx unknown
-
2014
- 2014-03-24 HK HK14102875.0A patent/HK1189810A1/zh unknown
-
2020
- 2020-11-29 US US17/106,141 patent/US20210077665A1/en active Pending
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101940553B (zh) * | 2009-07-10 | 2012-11-14 | 何彦津 | 叶酸-长春新碱靶向缓释纳米微球及制备方法及用途 |
CN102240265A (zh) * | 2010-05-14 | 2011-11-16 | 复旦大学 | 一种用于肿瘤的靶向递药的脂质体载体系统 |
CN102539760A (zh) * | 2012-02-11 | 2012-07-04 | 刘�东 | 具有体外肿瘤靶向作用的经叶酸配体修饰的氧化铁纳米颗粒与其制备方法及体外评价方法 |
CN103417468A (zh) * | 2012-05-25 | 2013-12-04 | 王世亮 | 一种依托泊苷植入剂 |
CN103417468B (zh) * | 2012-05-25 | 2016-01-20 | 王世亮 | 一种依托泊苷植入剂 |
CN103788385A (zh) * | 2013-12-31 | 2014-05-14 | 中国科学院深圳先进技术研究院 | 一种使用喷雾干燥法制备水凝胶光子晶体颗粒的方法 |
CN103788385B (zh) * | 2013-12-31 | 2016-01-13 | 中国科学院深圳先进技术研究院 | 一种使用喷雾干燥法制备水凝胶光子晶体颗粒的方法 |
CN107635455A (zh) * | 2015-04-03 | 2018-01-26 | 格勒诺布尔-阿尔卑斯大学 | 可植入肠反应器 |
CN107635455B (zh) * | 2015-04-03 | 2022-05-03 | 格勒诺布尔-阿尔卑斯大学 | 可植入肠反应器 |
CN109562130A (zh) * | 2016-06-13 | 2019-04-02 | 智能外科公司 | 用于生物系统的组合物以及制备和使用其的方法 |
CN109718228A (zh) * | 2017-10-30 | 2019-05-07 | 沈阳药科大学 | 米托蒽醌的抗肿瘤淋巴转移作用及其药物制剂 |
Also Published As
Publication number | Publication date |
---|---|
CN101287507B (zh) | 2012-12-05 |
ES2556974T3 (es) | 2016-01-21 |
EP1922094A1 (en) | 2008-05-21 |
CA2618807A1 (en) | 2007-02-22 |
HK1189810A1 (zh) | 2014-06-20 |
EP1922094A4 (en) | 2012-04-25 |
US20100278725A1 (en) | 2010-11-04 |
HK1123230A1 (en) | 2009-06-12 |
US20210077665A1 (en) | 2021-03-18 |
EP1922094B1 (en) | 2015-09-30 |
CN103315944B (zh) | 2016-03-30 |
CN103315944A (zh) | 2013-09-25 |
WO2007019678A1 (en) | 2007-02-22 |
CA2618807C (en) | 2015-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101287507B (zh) | 用于淋巴靶向的方法和装置 | |
Devnarain et al. | Intrinsic stimuli‐responsive nanocarriers for smart drug delivery of antibacterial agents—An in‐depth review of the last two decades | |
Sandhiya et al. | Emerging trends of nanomedicine–an overview | |
Bae et al. | Targeted drug delivery to tumors: myths, reality and possibility | |
Harfouche et al. | Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis | |
Dhanka et al. | Injectable methotrexate loaded polycaprolactone microspheres: physicochemical characterization, biocompatibility, and hemocompatibility evaluation | |
CN103877066B (zh) | 载多西他赛和莱菔硫烷的自组装纳米粒的制备方法与应用 | |
CN108273061A (zh) | 一种抗纤维化药物纳米制剂及其制备方法 | |
CN107233577A (zh) | 一种pH响应和肿瘤靶向的双载药纳米粒子及制备方法与应用 | |
CN106604749A (zh) | 靶向癌干细胞的碳纳米管‑药物递送系统、其制备方法及用途 | |
Massey et al. | Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment | |
CN102421418A (zh) | 在药物递送中有用的中空金纳米球(HAuNSs)和装载HAuNSs的微球体 | |
CN104666251A (zh) | 一种半乳糖胺和聚多巴胺修饰的肝癌靶向纳米粒及制备方法与应用 | |
Wu et al. | Recent advances in nanoplatforms for the treatment of osteosarcoma | |
Xiao et al. | Multifunctional PLGA microfibrous rings enable MR imaging-guided tumor chemotherapy and metastasis inhibition through prevention of circulating tumor cell shedding | |
Janrao et al. | Recent advances of polymer based nanosystems in cancer management | |
CN106063946A (zh) | 可吸收性氧化纤维素栓塞形成溶液 | |
Talimi et al. | Sirolimus-exuding core-shell nanofibers as an implantable carrier for breast cancer therapy: preparation, characterization, in vitro cell studies, and in vivo anti-tumor activity | |
Columbus et al. | Role of PEGylated CdSe-ZnS quantum dots on structural and functional properties of electrospun polycaprolactone scaffolds for blood vessel tissue engineering | |
CN103110567A (zh) | 一种载丹参酮iia的纳米给药系统的制备方法及用途 | |
Fan et al. | Fabrication of a composite 3D-printed titanium alloy combined with controlled in situ drug release to prevent osteosarcoma recurrence | |
CN102497886B (zh) | 用于细胞内药物递送的Fas(Apo-1,CD95)靶向平台 | |
Ye et al. | Bone metastasis target redox-responsive micell for the treatment of lung cancer bone metastasis and anti-bone resorption | |
Nozhat et al. | Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery | |
Raj et al. | Folic acid–egg white coated IPN network of carboxymethyl cellulose and egg white nanoparticles for treating breast cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1123230 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: JOHNSTON MICHAEL RICHARD WU XIAOYU Owner name: LIU JIANG Free format text: FORMER OWNER: UNIVERSITY HEALTH NETWORK Effective date: 20110301 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20110301 Address after: Ontario Applicant after: Liu Jiang Co-applicant after: Johnston Michael Richard Co-applicant after: Wu Xiaoyu Address before: Ontario Applicant before: Univ Health Network |
|
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: 214125 China in Jiangsu province Wuxi City Jinxi Road No. 100, building 1, room 1005 Applicant after: Liu Jiang Co-applicant after: Johnston Michael Richard Co-applicant after: Wu Xiaoyu Address before: Ontario Applicant before: Liu Jiang Co-applicant before: Johnston Michael Richard Co-applicant before: Wu Xiaoyu |
|
CI01 | Correction of invention patent gazette |
Correction item: Applicant Correct: Liu Jiang| 214125 China in Jiangsu province Wuxi City Jinxi Road No. 100, building 1, room 1005|M, R, Johnson| Wu Xiaoyu False: Liu Jiang| 214125 China in Jiangsu province Wuxi City Jinxi Road No. 100, building 1, room 1005|M, R, Johnson|Wu Xiaoyu Number: 28 Volume: 28 |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1123230 Country of ref document: HK |